company-logo

Idorsia Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases. Idorsia Ltd has a collaboration agreement with Janssen Biotech Inc. to jointly develop and commercialize aprocitentan and its derivative compounds or products; license agreement with Mochida Pharmaceutical for the supply, co-development, and comarketing of daridorexant; and Hoffman-La Roche Inc. to develop and market compounds in the field of cancer immunotherapy. It also has a collaboration with Antares Pharma, Inc. for the development of a self- administered drug device product for Selatogrel; and Neurocrine Biosciences, Inc. to develop and commercialize ACT-709478, which is in Phase II clinical trial for the treatment of epilepsy. The company was incorporated in 2017 and is headquartered in Allschwil, Switzerland.

Idorsia Dividend Announcement

Idorsia does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Idorsia dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Idorsia Dividend History

Idorsia Dividend Yield

Idorsia current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Idorsia stock? Use our calculator to estimate your expected dividend yield:

Idorsia Financial Ratios

P/E ratio5.97
PEG ratio-0.09
P/B ratio-0.16
ROE-3.03%
Payout ratio0.00%
Current ratio0.92
Quick ratio0.76
Cash Ratio0.57

Idorsia Dividend FAQ

Does Idorsia stock pay dividends?
Idorsia does not currently pay dividends to its shareholders.
Has Idorsia ever paid a dividend?
No, Idorsia has no a history of paying dividends to its shareholders. Idorsia is not known for its dividend payments.
Why doesn't Idorsia pay dividends?
There are several potential reasons why Idorsia would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Idorsia ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Idorsia has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Idorsia a dividend aristocrat?
Idorsia is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Idorsia a dividend king?
Idorsia is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Idorsia a dividend stock?
No, Idorsia is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Idorsia stocks?
To buy Idorsia you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Idorsia stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.